FLECS technology for high-throughput screening of hypercontractile cellular phenotypes in fibrosis: A function-first approach to anti-fibrotic drug discovery

Yao Wang(Incyte (United States)), Ivan Pushkarsky(Luceome Biotechnologies (United States))

SLAS DISCOVERY

December 28, 2023

10.1016/j.slasd.2023.12.010

Cited by 3

Related Papers

FLECS Technology for High-Throughput Screening of Hypercontractile Cellular Phenotypes in Fibrosis: A Function-First Approach to Anti-Fibrotic Drug Discovery

|bioRxiv (Cold Spring Harbor Laboratory)|2023|0